1 drug(s) with this reaction
542 total reports
Blood Parathyroid Hormone Increased has been reported as an adverse reaction across 1 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 542 adverse event reports mention blood parathyroid hormone increased in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with blood parathyroid hormone increased, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have blood parathyroid hormone increased listed in their FDA adverse event reports, sorted by report count:
In addition to blood parathyroid hormone increased, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
1 drug(s) manufactured by Amgen Inc have blood parathyroid hormone increased listed in their FDA adverse event reports: CINACALCET HYDROCHLORIDE.
There are a combined 542 reports of blood parathyroid hormone increased across 1 Amgen Inc drug(s) in the FDA adverse event database.